Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: VALTYA 1/35 — Supplemental Application (Xiromed LLC)

View source ↗

Summary

FDA approved a supplemental application for VALTYA 1/35 (ethynodiol diacetate and ethinyl estradiol) by Xiromed LLC, enabling continued supply of this generic o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTYA 1/35 (Ethynodiol diacetate and Ethinyl estradiol)

Snippet

SUPPL AP for VALTYA 1/35 (ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL)